Skip to content
Abierto
Menu

Combined synopsis and solicitation

Next Generation Sequencing System

75F40126Q134622

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

View on SAM.govMarkdown

Awarded

Illumina, Inc.

$53,442.90 obligated so far on USAspending

Description

As published on SAM.gov.

See attached combined synopsis/solicitation.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Illumina, Inc.
UEI
KMW3CRWNAAF3
CAGE
1WCS2
Vendor location
San Diego, CA
Contract
75F40126P00233, purchase order
Obligated
$53,442.90, potential $174,306
Actions
1 between August 28, 2026 and August 28, 2026
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Next Generation Sequencing System Miseq I100 System with Options for Post-Warranty Service Agreement and to Purchase Additional Systems. Eo 14398
Match
solicitation number 75F40126Q134622 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 28, 2026

    Combined synopsis and solicitation

    Due August 5, 2026 at 2:00 PM EDT. SAM.gov, notice ee03b2442bf34cd29a91a3dae6405eb7

Points of contact

Also open from this buyer